119 results
Page 3 of 6
8-K
EX-1.1
fvd9x9yhzjv
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
260f8 rze
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-10.2
l3cvp
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
5oqavauz 03le
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.3
5wwxivzbg rkmradj3e
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
5szqgqc
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
u1eucvj8m
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
kasl92j
26 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-1.1
trduyh
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
met5f6a9o3o5cbi2x
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
jrbmo3k uxr77219v
23 Jun 20
Prospectus supplement for primary offering
4:06pm